Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Quote Panel
Key Metrics
Fundamentals
Relative Strength
BLI
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Forecast
Analyst rating
Last analyst upgrade/downgrade
Earnings Growth
YoY
Current
Estimates
Q1.21
N/A
-0.24
vs -0.16
Q2.21
N/A
-0.27
vs -4.25
Q3.21
N/A
-0.30
vs -0.16
Q4.21
N/A
-0.26
vs -0.19
Q1.22
N/A
-0.32
vs -0.24
Q2.22
N/A
-0.38
vs -0.27
Q3.22
N/A
-0.32
vs -0.30
Q4.22
N/A
-0.41
vs -0.26
Q1.23
N/A
-0.31
vs -0.32
Q2.23
N/A
-0.00
vs -0.38
Sales Growth
YoY
Current
Estimates
Q1.21
+35%
18.6M vs 13.8M
Q2.21
+82%
19.3M vs 10.6M
Q3.21
+34%
24.3M vs 18.2M
Q4.21
+7%
23.2M vs 21.7M
Q1.22
+8%
20.2M vs 18.6M
Q2.22
-1%
19.1M vs 19.3M
Q3.22
-12%
21.4M vs 24.3M
Q4.22
-23%
17.8M vs 23.2M
Q1.23
-8%
18.5M vs 20.2M
Q2.23
-27%
14.1M vs 19.1M
Return on Equity
QoQ
Q3.21
-9%
-0.09
vs -0.08
Q4.21
-9%
-0.09
vs -0.09
Q1.22
-11%
-0.11
vs -0.09
Q2.22
-15%
-0.15
vs -0.11
Q3.22
-14%
-0.14
vs -0.15
Q4.22
-21%
-0.21
vs -0.14
Q1.23
-15%
-0.15
vs -0.21
Q2.23
-45%
-0.45
vs -0.15
Institutionnal Ownership
QoQ
Q4.21
139
139
vs 148
-6%
Q1.22
131
131
vs 139
-6%
Q2.22
120
120
vs 131
-8%
Q3.22
109
109
vs 120
-9%
Q4.22
119
119
vs 109
9%
Q1.23
105
105
vs 119
-12%
Q2.23
85
85
vs 105
-19%
Q3.23
56
56
vs 85
-34%
Quote Panel
Key Metrics
prnewswire.com
16 hours ago
prnewswire.com
16 hours ago
seekingalpha.com
22 hours ago
Berkeley Lights, Inc., a digital cell biology company, focuses on enabling and accelerating the rapid development and commercialization of biotherapeutics and other cell-based products. The company offers an integrated platform, which comprise of proprietary consumables, including OptoSelect chips and reagent kits, automation systems, and application and workflow software. It serves in North America, the Asia Pacific, and Europe. Berkeley Lights, Inc. was incorporated in 2011 and is headquartered in Emeryville, California.
NASDAQ
Unprofitable
EPS improving
Unprofitable
EPS improving
-0.07 ( -5.88%)
Relative Strenght
2
Volume Buzz
181%
Earning Acce
Yes
Dist 52w H.
84%Relative Strength
BLI
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Forecast
No Data Available
Analyst rating
Strong Sell
Sell
Buy
Neutral
Strong Buy
Buy
Price Target
NaN(-100.00%)
Number of analyst
Last analyst upgrade/downgrade
Morgan Stanley
downgradePrevious: Equal-Weight
2022-08-10
Now: Underweight
Citigroup
downgradePrevious: Not converted
2022-08-10
Now: Neutral
Fundamentals
P/E Ratio
P/S Ratio
P/B Ratio
Debt/Equity
Net Margin
EPS
How BLI compares to sector?
BLI
-1x